Back to Search
RENIER BRENTJENS, MD
MD
Internal Medicine Physician
NPI: 1588635510Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
209957(NY)
Research & Publications (20)
Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.
PMID 17855649·Clin Cancer Res·2007
7-preclinical
Novel approaches to immunotherapy for B-cell malignancies.
PMID 15610662·Curr Hematol Rep·2005
6-review
Somatic cell engineering and the immunotherapy of leukemias and lymphomas.
PMID 15464917·Adv Pharmacol·2004
6-review
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
PMID 12579196·Nat Med·2003
7-preclinical
Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host disease.
PMID 11477449·Bone Marrow Transplant·2001
5-case
Islet cell tumors of the pancreas: the medical oncologist's perspective.
PMID 11459269·Surg Clin North Am·2001
6-review
The promise and potential pitfalls of chimeric antigen receptors.
PMID 19327974·Curr Opin Immunol·2009
6-review
Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase.
PMID 19219023·Nat Med·2009
7-preclinical
Retroviral transduction of murine primary T lymphocytes.
PMID 19110621·Methods Mol Biol·2009
7-preclinical
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
PMID 19075280·J Clin Oncol·2009
4-observational
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
PMID 18376399·Nat Biotechnol·2008
7-preclinical
Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application.
PMID 18052719·Hum Gene Ther·2007
8-other
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection.
PMID 18026115·Nat Med·2007
7-preclinical
Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes.
PMID 17607040·J Nucl Med·2007
7-preclinical
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
PMID 16520464·J Clin Oncol·2006
8-other
Targeted elimination of prostate cancer by genetically directed human T lymphocytes.
PMID 16204083·Cancer Res·2005
7-preclinical
Novel strategies for cancer therapy: the potential of genetically modified T lymphocytes.
PMID 15217559·Curr Hematol Rep·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- ELM AND CARLTON ST
BUFFALO, NY 14263 - Phone
- (716) 845-2300
Quick Facts
- NPI
- 1588635510
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile